Humoral hypercalcemia in mixed endometrial carcinoma
DOI:
https://doi.org/10.23938/ASSN.0549Keywords:
Palabras clave. Hipercalcemia. Proteína relacionada con la hormona paratifoidea. Neoplasias uterinas. Síndromes paraneoplásicosAbstract
Hypercalcemia secondary to neoplastic disease is a frequent entity caused in the majority of cases by ectopic secretions of PTHrP. Despite this there are certain tumours, such as uterine carcinomas, in which this type of paraneoplastic manifestation has been described very little. We present a case of humoral hypercalcemia in a mixed endometrial carcinoma.Downloads
References
1. SAVVARI P, PEITSIDIS P, ALEVIZAKI M, DIMOPOULOS MA, ANTSAKLIS A, PAPADIMITRIOU CA. Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone-related protein in gynecologic malignancies: a sistematic review. Onkologie 2009; 32; 517-523.
https://doi.org/10.1159/000226209
2. STEWART AF. Hypercalcemia associated with cancer. N Engl J Med 2005; 352: 373-379.
https://doi.org/10.1056/NEJMcp042806
3. Guía clínica en formato electrónico. Murphy KC, Nakashima L, Kong K. BCCA Protocol summary guidelines for the diagnosis and management of malignancy related hypercalcemia. 2009; 1(1) (consultado 09-05-2010). Disponible en:
4. Guía clínica en formato electrónico. Colwell B, Reyno L, White D. Guidelines for the use of zoledronic acid for the treatment of tumor induced hypercalcemia QEII Health Sciences Centre/Cancer Care Nova Scotia. 2001; 1(1) (consultado 09-05-2010). Disponible en:
www.cancercare.ns.ca/site-cc/media/cancercare/ZoledronicAcid_Hypercalcemia_dg.pdf
5. HILLER N, SONNENBLICK M, HERSHKO C. Paraneoplastic hypercalcemia in endometrial carcinoma. Oncology 1989; 46; 45-48.
https://doi.org/10.1159/000226679
6. HORWITZ MJ. Hypercalcemia of malignancy. Uptodate versión 18.1 Monografía en formato electrónico 2010 (consultado 24-5-2010). Disponible en www.uptodate.com
7. HUTCHESSON A, DUNNE F, BUNDRED NJ, GEE H, RATCLIFFE WA. Parathyroid hormone-related protein as a tumour marker in humoral hypercalcemia associated with occult malignancy. Postgrad Med J 1993; 69: 640-642.
https://doi.org/10.1136/pgmj.69.814.640
8. SACHMECHI I, KALRA J, MOLHO L, CHAWLA K. Paraneoplastic hypercalcemia associated with uterine papillary serous carcinoma. Gynecol Oncol 1995; 58: 378-382.
https://doi.org/10.1006/gyno.1995.1246
9. TANG S, GEEVARGHESE S, SAAB S, MARTÍNEZ D, VAN HERLE A,WALLACE WD et al. A parathyroid hormone-related protein-secreting metastatic epithelioid leiomyosarcoma: case report and review of the literature. Arch Pathol Lab Med 2003; 127: e181-185.
https://doi.org/10.5858/2003-127-e181-APHPME
10. KINUGASA Y, MORISHIGE K, KAMIURA S, TSUKAMOTO Y, SAJI F. Parathyroid hormone-related protein-secreting uterine endometrioid adenocarcinoma. Jpn J Clin Oncol 2006; 36: 113-115.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
